3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
29
Rectal Neoplasms
8
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Cholangiocarcinoma
5
Stomach Neoplasms
4
Neoplasm Metastasis
4
Neoplasms
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Ovarian Neoplasms
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Solid Tumors
1
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Locally Advanced Rectal Cancer
1
Locally Advanced Colorectal Carcinoma
1
Liver Neoplasms
1
Gastroesophageal Junction Adenocarcinoma
1
Gastroesophageal Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Endometrial Neoplasms
1
Disease Progression
1
Colorectal Cancer Metastatic
1
Interventions
Injections
13
pembrolizumab
10
tislelizumab
9
toripalimab
6
atezolizumab
4
Nivolumab
4
Carboplatin
3
trastuzumab deruxtecan
2
olaparib
2
lenvatinib
2
Pemetrexed
2
Paclitaxel
2
Oxaliplatin
2
Gemcitabine
2
Fluorouracil
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Bevacizumab
2
zimberelimab
1
talazoparib
1
spartalizumab
1
sotorasib
1
serabelisib
1
penpulimab
1
niraparib
1
nedaplatin
1
mirdametinib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
Folfox protocol
×
1 year
×
Clear all
No trials found.